402 related articles for article (PubMed ID: 30156519)
21. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
[TBL] [Abstract][Full Text] [Related]
22. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
23. Humoral immune response to measles and varicella vaccination in former very low birth weight preterm infants.
Ferreira CSM; Perin MCAA; Moraes-Pinto MI; Simão-Gurge RM; Goulart AL; Weckx LY; Dos Santos AMN
Braz J Infect Dis; 2018; 22(1):41-46. PubMed ID: 29306654
[TBL] [Abstract][Full Text] [Related]
24. Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose.
Carazo Perez S; De Serres G; Bureau A; Skowronski DM
Clin Infect Dis; 2017 Oct; 65(7):1094-1102. PubMed ID: 28595358
[TBL] [Abstract][Full Text] [Related]
25. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
26. Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
Morikawa Y; Sakakibara H; Kimiya T; Obonai T; Miura M;
Vaccine; 2021 Sep; 39(39):5680-5687. PubMed ID: 34452773
[TBL] [Abstract][Full Text] [Related]
27. The combination measles, mumps, rubella and varicella vaccine in healthy children.
Arbeter AM; Baker L; Starr SE; Plotkin SA
Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
[TBL] [Abstract][Full Text] [Related]
30. The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.
Saffar MJ; Ajami A; Khalilian AR; Saffar H
Eur J Clin Microbiol Infect Dis; 2009 Jul; 28(7):845-7. PubMed ID: 19229565
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
32. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
[TBL] [Abstract][Full Text] [Related]
33. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
34. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
36. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
[TBL] [Abstract][Full Text] [Related]
37. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
[TBL] [Abstract][Full Text] [Related]
38. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
Rezahosseini O; Sørensen SS; Perch M; Ekenberg C; Møller DL; Knudsen AD; Kirkby N; Lundgren J; Lodding IP; Wareham NE; Gustafsson F; Rasmussen A; Nielsen SD
Clin Infect Dis; 2021 Dec; 73(11):e3733-e3739. PubMed ID: 32564061
[TBL] [Abstract][Full Text] [Related]
39. Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age.
Saffar H; Mousavi SJ; Saffar H; Parsaei MR; Ghorbani GR; Saffar MJ
BMC Immunol; 2022 Jan; 23(1):2. PubMed ID: 35034609
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.
Cho HK; Lee H; Kim HW; Kim SS; Kang HJ; Kim IT; Kim KH
J Korean Med Sci; 2016 Dec; 31(12):1957-1962. PubMed ID: 27822935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
